U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
181381181381Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem GliomaCompletedNo Results AvailableBrain Stem Neoplasms, Primary|Neoplasms, Brain StemDrug: Carboplatin|Drug: Thalomid|Procedure: External Beam Radiation Therapyhttps://ClinicalTrials.gov/show/NCT00179881
181382181382C-Reactive Protein as a Predictor of Stem Cell Transplant ComplicationsCompletedNo Results AvailableCancer|Leukemia|Stem Cell TransplantationBehavioral: C-Reactive Protein levelshttps://ClinicalTrials.gov/show/NCT00179868
181383181383Extracorporeal Photopheresis for Acute Graft Versus Host DiseaseRecruitingNo Results AvailableGraft Versus Host Disease|Cancer|Stem Cell TransplantationProcedure: Extracorporeal Photopheresishttps://ClinicalTrials.gov/show/NCT00179855
181384181384Immune Ablation and Stem Cell Support for Crohn's DiseaseWithdrawnNo Results AvailableCrohn DiseaseProcedure: Stem Cell Transplanthttps://ClinicalTrials.gov/show/NCT00179842
181385181385WT1 for the Detection of Minimal Residual DiseaseCompletedNo Results AvailableLeukemia|CancerProcedure: WT 1 Testinghttps://ClinicalTrials.gov/show/NCT00179829
181386181386Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid TumorsRecruitingNo Results AvailableEwing's Sarcoma|Soft Tissue Sarcoma|Hepatoblastoma|Hodgkin's Disease|Germ Cell TumorDrug: High-Dose Chemotherapy with Tandem PBSC Rescue.https://ClinicalTrials.gov/show/NCT00179816
181387181387Stem Cell Transplant for High Risk Central Nervous System (CNS) TumorsActive, not recruitingNo Results AvailableGlioblastoma|Astrocytoma|Pineoblastoma|Rhabdoid Tumor|Supratentorial NeoplasmsProcedure: Stem Cell Transplanthttps://ClinicalTrials.gov/show/NCT00179803
181388181388Reduced Intensity Transplant Using Extracorporeal PhotopheresisRecruitingNo Results AvailableLeukemia|CancerProcedure: Extracorporeal Photopheresishttps://ClinicalTrials.gov/show/NCT00179790
181389181389TRIGR - Primary Prevention Study for Type 1 Diabetes in Children at RiskActive, not recruitingNo Results AvailableDiabetes Mellitus, Type 1Dietary Supplement: hydrolysed vs nonhydrolysed infant formula vs breast feedinghttps://ClinicalTrials.gov/show/NCT00179777
181390181390Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC])RecruitingNo Results AvailableTumors|Malignant Melanoma|Hematological Malignancies|Myelogenous Leukemia, Chronic|Leukemia, Lymphoblastic, AcuteProcedure: Immunoablative Hematopoietic PBSC Transplant|Procedure: Busulfan pharmacokinetics|Radiation: CNS prophylaxis radiationhttps://ClinicalTrials.gov/show/NCT00179764
181391181391A Phase I/II Study of Lenalidomide in Combination With Gemcitabine in Patients With Untreated Advanced Carcinoma of the PancreasTerminatedNo Results AvailablePancreatic CancerDrug: CC-5013|Drug: gemcitabinehttps://ClinicalTrials.gov/show/NCT00179751
181392181392A Multicenter, Single-Arm, Open-Label, Study to Evaluate the Safety and Efficacy of Single-Agent Lenalidomide (Revlimid, CC-5013) in Subjects With Androgen Independent Prostate Cancer.TerminatedNo Results AvailableProstate CancerDrug: CC5013https://ClinicalTrials.gov/show/NCT00179738
181393181393Phase I/II Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile of Lenalidomide (Revlimid® CC-5013) With Liposomal Doxorubicin In Subjects With Advanced Ovarian and Primary Peritoneal CarcinomaTerminatedNo Results AvailableOvarian CancerDrug: CC-5013|Drug: liposomal doxorubicinhttps://ClinicalTrials.gov/show/NCT00179725
181394181394Study of Lenalidomide With Topotecan In Subjects With Advanced Ovarian and Primary Peritoneal CarcinomaCompletedNo Results AvailableOvarian CancerDrug: CC-5013|Drug: topotecanhttps://ClinicalTrials.gov/show/NCT00179712
181395181395Phase I Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile Of Lenalidomide (Revlimid®, CC-5013) With Pemetrexed In Subjects With Advanced Non-Small Cell Lung CancerTerminatedNo Results AvailableNon-Small Cell Lung CancerDrug: CC-5013|Drug: pemetrexedhttps://ClinicalTrials.gov/show/NCT00179699
181396181396A Study to Evaluate the Single-Agent Lenalidomide in Subjects With Recurrent Non-Small-Cell Lung CancerCompletedNo Results AvailableNon-Small Cell Lung CancerDrug: CC-5013https://ClinicalTrials.gov/show/NCT00179686
181397181397Lenalidomide (Revlimid®, CC-5013) in Subjects With Relapsed or Refractory Indolent Non-Hodgkin's LymphomaCompletedHas ResultsNon-Hodgkins LymphomaDrug: Lenalidomidehttps://ClinicalTrials.gov/show/NCT00179673
181398181398Safety And Efficacy Of Lenalidomide In Patients With Relapsed Or Refractory Aggressive Non-Hodgkin's Lymphoma (NHL)CompletedHas ResultsNon-Hodgkins LymphomaDrug: Lenalidomidehttps://ClinicalTrials.gov/show/NCT00179660
181399181399Expanded Access Program:Lenalidomide With or Without Dexamethasone In Previously Treated Subjects With Multiple MyelomaCompletedHas ResultsMultiple MyelomaDrug: lenalidomide|Drug: dexamethasonehttps://ClinicalTrials.gov/show/NCT00179647
181400181400Study of Fine Art Photographs and Visualization Tapes to Improve Surgical Recovery in Breast CancerTerminatedNo Results AvailableBreast NeoplasmsBehavioral: Visualization relaxation|Device: Visual Milieu Enhancement (Fine art photograph)https://ClinicalTrials.gov/show/NCT00179634
181401181401Lenalidomide Versus Placebo in Myelodysplastic Syndromes With a Deletion 5q[31] AbnormalityCompletedHas ResultsMyelodysplastic SyndromesDrug: Lenalidomide 5 mg|Drug: Lenalidomide 10 mg|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00179621
181402181402Study of the Combination of Lenalidomide and DTIC (Dacarbazine) in Patients With Metastatic Malignant Melanoma Previously Untreated With Systemic ChemotherapyCompletedNo Results AvailableMalignant MelanomaDrug: CC-5013https://ClinicalTrials.gov/show/NCT00179608
181403181403Does the Relaxation Response Inhibit Acute Stress?RecruitingNo Results AvailableHealthyBehavioral: relaxation response- meditationhttps://ClinicalTrials.gov/show/NCT00179595
181404181404Dose Ranging Study With the Probiotic Combination (VSL#3) in Diarrhea IBSActive, not recruitingNo Results AvailableIBSDrug: VSL#3https://ClinicalTrials.gov/show/NCT00179582
181405181405Molecular Processes of the Relaxation Response in Older AdultsCompletedNo Results AvailableStressBehavioral: Relaxation responsehttps://ClinicalTrials.gov/show/NCT00179569
181406181406Effects of Soy Isoflavones on Menopausal Hot FlashesActive, not recruitingNo Results AvailableMenopausal SymptomsDrug: Isoflavone supplementhttps://ClinicalTrials.gov/show/NCT00179556
181407181407Mechanisms and Therapeutic Effects of the Relaxation Response in Elderly Hypertensive PatientsCompletedNo Results AvailableHypertensionBehavioral: Relaxation responsehttps://ClinicalTrials.gov/show/NCT00179543
181408181408The Effect of Relaxation Response Training on Declarative Memory and Salivary Cortisol in Older AdultsCompletedNo Results AvailableHealthyBehavioral: Relaxation Responsehttps://ClinicalTrials.gov/show/NCT00179530
181409181409Treatment of Sexual Dysfunction in Men With Epilepsy With Testosterone and Either Arimidex or PlaceboCompletedNo Results AvailableSeizure Disorder|Hypogonadism|Erectile DysfunctionDrug: Arimidexhttps://ClinicalTrials.gov/show/NCT00179517
181410181410The Effect of Relaxation Response Training on Declarative Memory and Learning in High School StudentsCompletedNo Results AvailableHealthyBehavioral: Relaxation Responsehttps://ClinicalTrials.gov/show/NCT00179504

* Görseller ve İçerik tekif hakkına sahip olabilir